HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100Deal TrackerResearchCompany Lookup
The Week

Havas Lynx revamps New York C-suite 16 months after last shakeup

Havas Lynx has shaken up the leadership of its New York team, expanding Claire Knapp's role to cover the office and hiring Bruno Rebelo to head up its creative division.

By FiercePharma · Jul 28, 2026 · via FiercePharma

This is an aggregated industry headline. Read the full story at FiercePharma →

RxInsider combines reported facts with industry analysis and informed inference. Forward-looking reads, market commentary, and interpretive framing reflect analysis of available reporting and known facts, not confirmed outcomes.

Tags
theweekformat:headlineheadlineFiercePharma
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from The Week
All The Week →
The WeekFierceBiotech ↗
RA Capital launches rare disease company Oak Hill Bio onto Nasdaq via SPAC
Rare disease biotech Oak Hill is headed to the Nasdaq through a SPAC merger with RA Capital-sponsored Research…
Jul 28, 2026
Otsuka’s Simtriyo approval opens a new ADHD launch story
The WeekBriefing
Otsuka’s Simtriyo approval opens a new ADHD launch story
FDA approval of Otsuka’s Simtriyo gives the company a first-in-class ADHD asset. The real question now is whet…
Jul 28, 2026
The WeekDrug Channels ↗
Drug Channels News Roundup, Mid-July 2026: Biosimilar Launch Strategy, Part D Spending Trends, Rural 340B Hospitals, What Employers Can Do About 340B, and Drug Channel Villains
By Bryce Platt, PharmD Summer's in full swing, but the drug channel didn't take a break. What better way to sp…
Jul 28, 2026